131 related articles for article (PubMed ID: 17683382)
1. Suppressor of cytokine signaling 3 negative regulation of signal transducer and activator of transcription 3 in platelet-derived growth factor-induced fibroblast migration.
Nagai H; Tokumaru S; Sayama K; Shirakata Y; Hanakawa Y; Hirakawa S; Dai X; Tohyama M; Yang L; Hashimoto K
J Dermatol; 2007 Aug; 34(8):523-30. PubMed ID: 17683382
[TBL] [Abstract][Full Text] [Related]
2. PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway.
Vij N; Sharma A; Thakkar M; Sinha S; Mohan RR
Mol Vis; 2008 May; 14():1020-7. PubMed ID: 18523665
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons.
Miao T; Wu D; Zhang Y; Bo X; Subang MC; Wang P; Richardson PM
J Neurosci; 2006 Sep; 26(37):9512-9. PubMed ID: 16971535
[TBL] [Abstract][Full Text] [Related]
4. SOCS3/CIS3 negative regulation of STAT3 in HGF-induced keratinocyte migration.
Tokumaru S; Sayama K; Yamasaki K; Shirakata Y; Hanakawa Y; Yahata Y; Dai X; Tohyama M; Yang L; Yoshimura A; Hashimoto K
Biochem Biophys Res Commun; 2005 Feb; 327(1):100-5. PubMed ID: 15629435
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92.
Braunschweig A; Poehlmann TG; Busch S; Schleussner E; Markert UR
Am J Reprod Immunol; 2011 Oct; 66(4):329-35. PubMed ID: 21385272
[TBL] [Abstract][Full Text] [Related]
6. [Effects of exogenous suppressor of cytokine signaling on cell apoptosis in ectopic endometrial stromal cells].
Li M; Ruan F; Zhan H; Fei X; Ma J; Lin J
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(1):55-8. PubMed ID: 24721309
[TBL] [Abstract][Full Text] [Related]
7. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
[TBL] [Abstract][Full Text] [Related]
8. SOCS3 negatively regulates the gp130-STAT3 pathway in mouse skin wound healing.
Zhu BM; Ishida Y; Robinson GW; Pacher-Zavisin M; Yoshimura A; Murphy PM; Hennighausen L
J Invest Dermatol; 2008 Jul; 128(7):1821-9. PubMed ID: 18185532
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation.
Dimitriadis E; Stoikos C; Tan YL; Salamonsen LA
Endocrinology; 2006 Aug; 147(8):3809-17. PubMed ID: 16709613
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2516-28. PubMed ID: 17636039
[TBL] [Abstract][Full Text] [Related]
12. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
Ogata H; Chinen T; Yoshida T; Kinjyo I; Takaesu G; Shiraishi H; Iida M; Kobayashi T; Yoshimura A
Oncogene; 2006 Apr; 25(17):2520-30. PubMed ID: 16474852
[TBL] [Abstract][Full Text] [Related]
13. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury.
Okada S; Nakamura M; Katoh H; Miyao T; Shimazaki T; Ishii K; Yamane J; Yoshimura A; Iwamoto Y; Toyama Y; Okano H
Nat Med; 2006 Jul; 12(7):829-34. PubMed ID: 16783372
[TBL] [Abstract][Full Text] [Related]
14. Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells.
Baus D; Pfitzner E
Int J Cancer; 2006 Mar; 118(6):1404-13. PubMed ID: 16206268
[TBL] [Abstract][Full Text] [Related]
15. A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation.
Pirvulescu M; Manduteanu I; Gan AM; Stan D; Simion V; Butoi E; Calin M; Simionescu M
Biochem Biophys Res Commun; 2012 Jun; 422(2):321-6. PubMed ID: 22575502
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Wu ZS; Cheng XW; Wang XN; Song NJ
Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
[TBL] [Abstract][Full Text] [Related]
17. Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma.
Cui Q; Jiang W; Wang Y; Lv C; Luo J; Zhang W; Lin F; Yin Y; Cai R; Wei P; Qian C
Hepatology; 2008 Jan; 47(1):105-12. PubMed ID: 17935223
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SOCS3 inhibits astrogliogenesis and promotes maintenance of neural stem cells.
Cao F; Hata R; Zhu P; Ma YJ; Tanaka J; Hanakawa Y; Hashimoto K; Niinobe M; Yoshikawa K; Sakanaka M
J Neurochem; 2006 Jul; 98(2):459-70. PubMed ID: 16805839
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
Setsu N; Kohashi K; Endo M; Yamamoto H; Tamiya S; Takahashi Y; Yamada Y; Ishii T; Matsuda S; Yokoyama R; Iwamoto Y; Oda Y
Int J Cancer; 2013 Jan; 132(1):109-15. PubMed ID: 22644781
[TBL] [Abstract][Full Text] [Related]
20. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37.
Tokumaru S; Sayama K; Shirakata Y; Komatsuzawa H; Ouhara K; Hanakawa Y; Yahata Y; Dai X; Tohyama M; Nagai H; Yang L; Higashiyama S; Yoshimura A; Sugai M; Hashimoto K
J Immunol; 2005 Oct; 175(7):4662-8. PubMed ID: 16177113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
